Vortioxetine clinical trials
Also written Brintellix, Lu AA21004, Trintellix and LuAA21004.
How each study uses Vortioxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Vortioxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Sept 2013 · TRINTELLIX · NDA 204447 (FDA, Drugs@FDA)
- European Union
- 18 Dec 2013 · Brintellix · EMEA/H/C/002717 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
98 studies that test it; most in 2016 (16)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 11 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 6 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 16 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 62 · Other 36
H. Lundbeck A/S (34) · Takeda (25) · Washington University School of Medicine (2) · Brain and Cognition Discovery Foundation (2) · University of Miami (2) · Massachusetts General Hospital (2) · Johns Hopkins University (2) · Northwell Health (1)
Often tested with
Tested in the same studies.
Sertraline (2) · Dasatinib (1) · Quercetin (1) · SSRIs (1) · Cariprazine (1) · Fluoxetine (1) · Duloxetine (1) · Aripiprazole (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Vortioxetine is the comparator. A study of two new drugs counts under both.
- 1KH607 · Chengdu Kanghong Pharmaceutical Group Co., Ltd. · next primary completion Dec 2027
Reaching primary completion within a year · 2
Studies that test Vortioxetine.
- Dec 2026Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson DiseasePhase 4 · Marianna Amboni
- Dec 2026Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)Phase 1/2 · First Affiliated Hospital of Chongqing Medical University
Studies
Open first, then newest update. How each study uses Vortioxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 98
- A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive DisorderRecruitingPhase 3TakedaNCT07204314Written as Vortioxetine tablets
- Vortioxetine for Newly Diagnosed GlioblastomaRecruitingPhase 2University of ZurichNCT07284628Written as Vortioxetine
- RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)RecruitingPhase 4Mayo ClinicNCT07266545Written as Vortioxetine
- Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaRecruitingPhase 2Johns Hopkins UniversityNCT06604520Written as Vortioxetine
- Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)RecruitingPhase 1/2First Affiliated Hospital of Chongqing Medical UniversityNCT05814640Written as Vortioxetine
- Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson DiseaseNot yet recruitingPhase 4Marianna AmboniNCT06805266Written as Vortioxetine (tablet)
- Cognitive Effects of Adjuvant Vortioxetine in Early SchizophreniaRecruitingPhase 2/3Fundación Pública Andaluza para la gestión de la Investigación en SevillaNCT04895488Written as Vortioxetine
- Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth SyndromeRecruitingPhase 3Federico II UniversityNCT06025474Written as Vortioxetine 20Mg Tab
- Tolerability, Safety and Efficacy of VortioxetineRecruitingPhase 4IRCCS San Raffaele RomaNCT04301492Written as Vortioxetine
- Postoperative Pain Management Following Laparoscopic CholecystectomyCompletedPhase 3Future University in EgyptNCT06561438Written as Vortioxetine 20Mg Tab
- Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot StudyCompletedPhase 2Washington University School of MedicineNCT07000734Written as Vortioxetine
- THINC-it Vortioxetine - Sensitivity to ChangeCompletedPhase 2/3Brain and Cognition Discovery FoundationNCT03053362Written as Vortioxetine
- Vortioxetine for Post-COVID-19 ConditionCompletedPhase 2Brain and Cognition Discovery FoundationNCT05047952Written as Vortioxetine
- Adjunctive Vortioxetine in SchizophreniaActive, not recruitingPhase 4Northwell HealthNCT02357797Written as Vortioxetine
- Vortioxetine for the Treatment of Hoarding DisorderWithdrawnPhase 3Noam SoreniNCT04035850Written as Vortioxetine Tablets
- Vortioxetine Adjunctive Treatment in Bipolar DepressionCompletedPhase 4First Affiliated Hospital of Zhejiang UniversityNCT05481957Written as Vortioxetine
- Substance Misuse To Psychiatric Disorders for CannabisCompletedPhase 2/3The University of Hong KongNCT03485274Written as Vortioxetine
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedPhase 4Azienda Ospedaliera Universitaria Integrata VeronaNCT03779789Written as Vortioxetine
- Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsCompletedPhase 1Seasons Biotechnology (Taizhou) Co., Ltd.NCT05417087Written as Vortioxetine Hydrobromide Tablets
- Vortioxetine to Prevent Return of Symptoms in Children With DepressionTerminatedPhase 3H. Lundbeck A/SNCT05014919Written as Vortioxetine
See all 98 studies that test Vortioxetine →
As the comparator · 2 — what is tested is compared with Vortioxetine
- Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets in Adult Patients With Major Depressive DisorderNot yet recruitingPhase 3Chengdu Kanghong Pharmaceutical Group Co., Ltd.NCT07741331Written as Vortioxetine Hydrobromide Tablets
- Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)WithdrawnPhase 3Naurex, Inc, an affiliate of Allergan plcNCT03855865Written as Vortioxetine
Codes
What other systems call Vortioxetine · ClinicalTrials.gg INT006835
- MeSH (NLM) D000078784VortioxetineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3O2K1S3WQVVORTIOXETINEConfirmed FDA, NLM, Wikidata
- RxNorm 1455099Confirmed FDA, Wikidata
- Wikidata Q3563148vortioxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152917VortioxetineOne source FDA
- DrugBank DB09068One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078784 | Vortioxetine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3O2K1S3WQV | VORTIOXETINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1455099 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3563148 | vortioxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152917 | Vortioxetine | One source FDA |
| DrugBank | DB09068 | — | One source Wikidata |
Also registered as vortioxetine hydrobromide (UNII TKS641KOAY · RxNorm 1439834).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.